莲花健康(600186) - 2020 Q3 - 季度财报
LHGLHG(SH:600186)2020-10-30 16:00

Financial Performance - Net profit attributable to shareholders decreased by 44.03% to CNY 52,333,114.38 year-on-year[17] - Operating revenue for the first nine months was CNY 1,209,529,582.00, a decrease of 7.78% compared to the same period last year[17] - Basic earnings per share dropped by 56.93% to CNY 0.0379[19] - The company reported a net loss of approximately ¥1.62 billion, slightly improved from a loss of ¥1.67 billion in the previous year[45] - The total profit for Q3 2020 was ¥27,808,981.70, while the total loss in Q3 2019 was ¥42,450,897.50[56] - The net profit for Q3 2020 was ¥20,933,660.86, compared to a net loss of ¥42,450,897.50 in Q3 2019[57] - The total profit for the current period is 27,501,283.32, compared to a loss of 26,883,327.91 in the same period last year[65] - The net profit for the current period is 20,625,962.48, while the previous year showed a net loss of 26,883,327.91[67] Cash Flow - Net cash flow from operating activities was negative at CNY -751,058,483.84, compared to CNY -80,012,376.98 in the same period last year[17] - Cash inflow from operating activities for the current period is 1,296,802,065.12, an increase from 1,257,984,287.66 in the previous year[66] - Cash outflow from operating activities is 2,047,860,548.96, compared to 1,337,996,664.64 in the same period last year[70] - The net cash flow from operating activities was -686,851,078.97 RMB, a significant decline compared to -39,689,956.41 RMB in the same period last year[74] - Total cash inflow from operating activities was 890,352,851.61 RMB, down from 1,128,908,582.63 RMB year-over-year[74] - Cash outflow from operating activities totaled 1,577,203,930.58 RMB, compared to 1,168,598,539.04 RMB in the previous year[74] - Cash flow from investing activities shows a net outflow of -48,745,557.67, compared to -1,622,346.40 last year[70] - The net cash flow from investing activities was -86,329,800.00 RMB, worsening from -832,971.46 RMB year-over-year[74] - Cash outflow from investing activities was 86,790,000.00 RMB, compared to 1,496,550.46 RMB in the same period last year[74] - The net cash flow from financing activities was -232,019,791.24 RMB, compared to 39,160,000.00 RMB in the previous year[74] Assets and Liabilities - Total assets decreased by 36.31% to CNY 1,371,072,946.62 compared to the end of the previous year[17] - The total assets decreased to RMB 1,371,072,946.62 from RMB 2,152,656,203.22[40] - Non-current assets totaled RMB 574,837,802.69, down from RMB 597,299,692.83[40] - The company's total liabilities decreased to approximately ¥502 million from ¥1.52 billion year-over-year, indicating a significant reduction in financial obligations[50] - The total owner's equity was approximately ¥462 million, an increase from ¥409 million, showing a positive trend in shareholder value[50] Shareholder Information - The total number of shareholders at the end of the reporting period was 68,903[26] - The largest shareholder, Wuhu Lian Tai Investment Management Center, holds 10.04% of the shares[26] Operational Metrics - The company's cash and cash equivalents decreased by 67.35% to RMB 395,997,350.87 from RMB 1,212,960,609.73 due to payments for debt restructuring[29] - Accounts receivable increased by 94.13% to RMB 3,921,480.13 from RMB 2,020,000.00, attributed to sales received via bank acceptance bills[29] - Prepayments rose by 97.65% to RMB 161,622,776.19 from RMB 81,770,185.84, driven by increased advance payments for projects and purchases[29] - Construction in progress surged by 1,309.24% to RMB 3,020,066.43 from RMB 214,304.62, reflecting new projects in the new district[29] - Short-term borrowings increased to RMB 50,000,000.00 during the period[29] - Accounts payable rose by 125.92% to RMB 355,600,000.00 from RMB 157,400,000.00, due to increased procurement of goods and issuance of bank acceptance bills[29] - Employee compensation payable decreased by 88.66% to RMB 94,035,617.90 from RMB 829,110,024.91, as payments for restructured employee debts were made[31] - Other payables decreased by 39.01% to RMB 411,816,031.98 from RMB 675,227,660.93, also related to payments for debt restructuring[31] Research and Development - The company has not disclosed any new product or technology developments in this report[17] - Research and development expenses for Q3 2020 were ¥475,711.36, consistent with the previous year's figures[54]